Innovaro Inc
OTC:INNI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (12), the stock would be worth $-1.43 (12 028% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | $0.01 |
0%
|
| Industry Average | 12 | $-1.43 |
-12 028%
|
| Country Average | 21.9 | $-2.61 |
-21 848%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
I
|
Innovaro Inc
OTC:INNI
|
271.3k USD | -0.1 | -0.1 | |
| UK |
|
Relx PLC
LSE:REL
|
49.1B GBP | 17.5 | 23.8 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 60 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
57.8B CAD | 36.7 | 27.8 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25B GBP | 23 | 24.8 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
25.1B USD | 9.1 | 27.6 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.3B CHF | 9.9 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.7B USD | 14 | 29.7 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.9B USD | 13.1 | 13 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.4B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 7.3 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
Innovaro Inc
Glance View
Innovaro, Inc. operates as an innovation solutions company. The company is headquartered in Tampa, Florida and currently employs 7 full-time employees. The company went IPO on 2000-10-25. The firm intends to provide integrated range of solutions through its partners in solutions, service delivery and new technology. The company shares its community's insights, inspiration, collaboration, ideas, experiments and operational disciplines. Its Innovation Diagnostic helps users to understand the symptoms and to determine the underlying causes. Innovation Diagnostic is a focused diagnostic in areas, which include innovation strategy and alignment, finance, culture, capability, lifecycle/process and management. The company offers systematic innovation lifecycle, which is supported by over six unified disciplines, such as strategy, management, process, infrastructure, culture and ecosystem. Its Assessment Solution provides users with the understanding of what is working, what is not working, user's strengths and weaknesses, and gaps. Its Partner Alliance Program intends to allow members to develop joint information technology (IT) solutions.
